Prosthetic Heart Valve Thrombosis
📧 Sign up to get email alerts when something new happens for Prosthetic Heart Valve Thrombosis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2025-07-02FDA Approved: WARFARIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Warfarin Sodium by Teva Pharmaceuticals USA, Inc., resulting in changes to the product labeling.…
-
FDA approval · 2022-08-23FDA Approved: WARFARIN SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Warfarin sodium submitted by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT [Phase 4]
The INRange Phase 4 trial evaluated whether timing of warfarin dosing affects anticoagulation stability in patients with atrial fibrillation…
-
CLINICAL_TRIALS research · 2017-03-10Clinical Trial Update: Surgery Versus Fibrinolytic Therapy for Left-sided Prosthetic Heart Valve Thrombosis [Phase 3]
Phase 3 clinical trial update comparing surgery with fibrinolytic therapy for left-sided prosthetic heart valve thrombosis; current status i…
-
FDA approval · 2006-05-05FDA Approved: JANTOVEN — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for JANTOVEN (warfarin sodium) from Upsher-Smith Laboratories, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.